Highly variable mutational profile of ASXL1 in myelofibrosis.

about

Highly variable mutational profile of ASXL1 in myelofibrosis.

Item

http://www.wikidata.org/entity/Q41012858

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Highly variable mutational profile of ASXL1 in myelofibrosis.

@en

type

Item

label

Highly variable mutational profile of ASXL1 in myelofibrosis.

@en

prefLabel

Highly variable mutational profile of ASXL1 in myelofibrosis.

@en

P1476

Highly variable mutational profile of ASXL1 in myelofibrosis.

@en

P2093

Concepción Boqué

http://www.w3.org/2001/XMLSchema#string

Cristalina Fernández

http://www.w3.org/2001/XMLSchema#string

Esther Plensa

http://www.w3.org/2001/XMLSchema#string

Evarist Feliu

http://www.w3.org/2001/XMLSchema#string

Joan Buch

http://www.w3.org/2001/XMLSchema#string

Marta Cabezón

http://www.w3.org/2001/XMLSchema#string

Montserrat Cortes

http://www.w3.org/2001/XMLSchema#string

Olga García

http://www.w3.org/2001/XMLSchema#string

Patricia Vélez

http://www.w3.org/2001/XMLSchema#string

Silvia Marcé

http://www.w3.org/2001/XMLSchema#string

P2860

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients.

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.

Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias.

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value.

Functional and cancer genomics of ASXL family members

Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms.

The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration.

P304

331-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12731

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26714837

http://www.w3.org/2001/XMLSchema#string